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eativecommons.org/licenses/by-nc-Summary Ectopic sebaceous glands (ESGs) are benign esophageal lesions that have a lower
detection rate than malignant lesions because most patients are asymptomatic. However, this
rate can be increased by the widespread use of endoscopes and an increasing awareness of the
disease. Through esophagogastroduodenoscopy, ESGs often appear in the middle and lower
esophagus in numbers ranging from 1 to more than 100 yellowish plaques measuring 1
e2 mm in diameter. Histopathological examination of ESGs would reveal small lobular cluster
glands in the lamina propria. Diagnosis is usually confirmed through an endoscopic biopsy. ESGs
are best distinguished from other yellowish lesions such as xanthoma via endoscopy. These le-
sions tend to appear singly scattered, whereas xanthomas tend to be clustered. We present
three cases of ESGs in the esophagus. Although their etiologies are still unclear, we present
related theories in our review.
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Esophageal benign lesions have been detected less often
than malignant lesions, accounting for only 0.5% of autopsy
cases, because most patients are asymptomatic [1]. How-
ever, benign esophageal lesions can be detected more
often by the widespread use of endoscopes and an
increasing awareness of the disease. Sebaceous glands are
normally found in human hair follicles, but ectopic areas
have been reported around the eyes and in the oral cavity,
tongue, larynx, palms, soles, and external genitalia, which
are lined with squamous cells. Sebaceous glands in the
esophagus were first reported in 1962 by De La Pava and
Pickren [2] and are rarely found. The apparent lowFigure 1 EGD revealed a single 0.3-cm yellowish plaque at
33 cm from the incisor. It presented as a slightly elevated shape
with an uneven surface. EGDZ esophagogastroduodenoscopy.
Figure 2 (A) Esophageal mucosa covered by benign squamous ep
sebaceous cells (arrows) (H&E, 200). IHC statins: (B) positive for C
for mucin. H&E Z hematoxylin and eosin; IHC Z Immunohistocheincidence of this condition may be because of the lack of
obvious clinical signs and symptoms. Most cases were
discovered incidentally by endoscopy in patients referred
for gastrointestinal tract examination.
Ectopic sebaceous glands (ESGs) are best distinguished
from other yellowish plaques such as xanthoma through
endoscopy. Esophageal xanthomaswerefirst reported in 1984
by Remmele and Engelsing [3]. One study showed that the
most common location of xanthoma was the stomach (76%),
followed by the esophagus (12%) and duodenum (12%) [4].
Coincidently, both ESGs and xanthomas are detected in the
lower esophagus and should be confirmed via tissue biopsy.
Understanding the endoscopic and pathological features
of esophageal lesions is essential for the detection, dif-
ferential diagnosis, and management of ESGs and xantho-
mas. These two rare esophageal benign lesions are difficult
to differentiate according to morphology. This study com-
pares the differences between these benign lesions in the
esophagus.Case reports
Case 1
A 67-year-old man presented at our outpatient department
with a 10-month history of epigastralgia and abdominal
fullness. No significant abnormality was found on physical
examination or laboratory tests. Esophagogastroduodeno-
scopy (EGD) revealeda0.3 cm, single, yellowishplaque33 cm
from an incisor. The plaque presented as a slightly elevated
shapewith an uneven surface (Figure 1A). Amucosal break of
about 3 mm was found in the lower esophagus, which was
diagnosed as a gastroesophageal reflux disease, Los Angeles
class A. Histopathological examination of a resected spec-
imen revealed esophageal mucosa covered by benign squa-
mous epithelium with focal ESGs composed of sebaceous
cells (Figure 2A). The immunohistochemical staining wasithelium with focal heterotopic sebaceous glands composed of
K; (C) positive for P40; (D) negative for CD68; and (E) negative
mistry.
Figure 3 EGD revealed two tiny yellowish plaques in the
lower esophagus. It presented as a slightly elevated shape with
an uneven surface. EGD Z esophagogastroduodenoscopy.
120 L.-S. Jhang et al.positive for cytokeratin (Figure 2B), and a small number of
cells were positive for P40 (Figure 2C) but negative for CD68
(Figure 2D) and mucin (Figure 2E). Lymphocyte infiltration
was present in adjacent tissue.
Case 2
A 65-year-old woman presented at our clinic because of
intermittent epigastralgia for some time. She denied
smoking or alcohol drinking. EGD revealed two tiny
yellowish plaques in her lower esophagus. The plaques
presented as slightly elevated shapes with uneven surfaces
(Figure 3). Histopathological examination revealed that the
esophageal mucosa was covered by benign squamous
epithelium with focal ESGs.Figure 4 EGD revealed more than 100 tiny yellowish dots,
0.1 cm in diameter, scattered throughout the upper and lower
esophagus. EGD Z esophagogastroduodenoscopy.Case 3
A 44-year-old woman presented at our clinic with inter-
mittent epigastralgia and fullness accompanied by nausea
and vomiting. EGD revealed more than 100 tiny yellowish
dots of 0.1 cm in diameter scattered throughout the upper
and lower esophagi (Figure 4). ESGs present as small lobules
embedded in the lamina propria on histological
examination.Discussion
ESGs and xanthomas in the esophagus (Figure 5) have
similar epidemiology, such as patient age (mean, 50 years),
endoscopic features (yellowish, small, mildly elevated le-
sions), and clinical symptoms (asymptomatic), with good
prognoses. To the best of our knowledge, no case reports
have discussed their differences. We present three cases of
ESGs and one case of xanthoma in the esophagus that had
similar endoscopic findings and age distributions. A com-
parison between the esophageal ESGs and xanthoma is
provided in Table 1.
ESGs and xanthomas are rarely found in the esophagus.
For ESGs in the esophagus, the typical mean patient age at
onset is 50 years, with almost equal distribution in men and
women [5]. For esophageal xanthoma, also known as
“xanthelasma” and “lipid island,” the mean patient age at
onset is 54 years, with mild predominance in men [6,7].
ESGs are most likely the result of a metaplastic process
rather than a congenital anomaly. As ESGs are derived from
endodermal tissue, it is unlikely that they are derived from
ectodermal tissue [8]. ESGs are rarely found in infants or
children, supporting the belief that they are less likely to
be a congenital anomaly [9]; rather, ESGs are suspected to
be associated with reflux gastritis. Accordingly, the theory
of an acquired metaplastic change of the esophagealFigure 5 EGD revealed some well-defined, fern-like,
yellowish lesions scattered over the middle and lower esoph-
agus. EGD Z esophagogastroduodenoscopy.
Table 1 Comparison between ectopic sebaceous glands and xanthoma.
Ectopic sebaceous gland Xanthoma
Prevalence Middle age, equal between men and women Middle age, mild predominance in men
Possible pathogenesis Metaplastic process; may be associated
with reflux gastritis
May derive from focal mucosal damage
Endoscopic features Single Clusters
Yellowish Yellowish
Located in the lower esophagus Located in the lower esophagus
<5 mm 2e10 mm
Papular surface with irregular margin Fern-like plaque
Histopathological features Small lobules embedded in the lamina propria that
contain an excretory duct without hair follicles
Foamy macrophages distributed in the
lamina propria with central or eccentric
nuclei
Clinical significance Asymptomatic Asymptomatic
Recommended management Good prognosis Good prognosis
Observation alone Observation alone
Ectopic sebaceous gland in the esophagus 121epithelium was suggested in a 79-year-old man [10]. Only
one of our patients had gastroesophageal reflux disease. All
the patients were diagnosed with ESG in the lower esoph-
agus. In our opinion, the theory of acquired metaplastic
change is possible, but there is not enough evidence to
support it.
The etiology of esophageal xanthomas is still unknown.
One study reported a theory that gastric xanthoma is
derived from focal mucosal damage in which the lipids were
derived from broken-down cell membranes and captured by
interstitial histiocytes [11]. This may explain why the
esophageal mucosa has a better tolerance to damage than
the gastric mucosa and the fewer reports of xanthoma in
the esophagus [4]. No significant associated clinical symp-
toms or signs have been reported.
For ESGs in the esophagus, the number of occurrences
has ranged from 1 to more than 100 (which was consistent
with the findings in our patients), and lesion sizes have
ranged from 1 mm to 20 mm, with the majority of cases
being smaller than 0.5 cm [12]. Factors that affect the
pattern and distribution of ESGs in the esophagus require
further study. They have several different shapes and a
yellowish appearance; smaller lesions are flat or dome
shaped, or have a papular surface with irregular margins.
Esophageal xanthomas are located most often in the lower
esophagus and are about 2e10 mm in size [7]. They appear
as well-defined, fern-like yellowish plaques scattered over
the middle or lower esophagus, with the plaques being
composed of clusters or groups.
Coincidently, both ESGs and xanthomas are detected in
the lower esophagus and should be confirmed via tissue
biopsy. On histological examination, ESGs present as small
lobules embedded in the lamina propria that contain an
excretory duct without hair follicles. Immunohistochemical
staining shows keratin expression, especially for antikeratin
[10]. In Case 1, the immunohistochemical stain was positive
for cytokeratin but negative for CD68, mucin, periodic acid
Schiff, or periodic acid Schiff with diastase. We also found a
small number of cells positive for P40. The xanthoma pre-
sented as foamy macrophages distributed in the lamina
propria of the mucosa, with small nuclei located centrally
or eccentrically [7].We are still unsure of the detailed etiology of benign
esophageal ESGs and xanthomas, in which patients have
similar age at onset, endoscopic morphology, and clinical
symptoms. ESGs tend to appear singly scattered, whereas
xanthomas tend to be clustered. However, distinguishing
them according to endoscopic findings alone remains a
challenge. Most cases had no significant overall changes in
ESG number, size, or shape during follow-up. We suggest
that ESGs do not need further treatment.
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